<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Johnson DT</submitter><funding>NCI NIH HHS</funding><pagination>3727-38</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3567628</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>288(6)</volume><pubmed_abstract>Using an Lzts2 knock-out mouse model, we characterized the biological role of Lzts2 in tumorigenesis. Both heterozygous and homozygous deletion of the Lzts2-targeted allele in mice shows an increased incidence in spontaneous tumor development, although Lzts2 homozygous knock-out mice show significantly higher incidences than heterozygous mice. Treatment of Lzts2-deficient mice with a carcinogen, N-butyl-N-(4-hydroxybutyl) nitrosamine, increases the susceptibility to N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder carcinoma development. Examination of human prostate cancer tissue specimens shows a reduction of LZTS2 protein expression in prostate cancer cells. Further analyses of mouse embryonic fibroblasts isolated from Lzts2 knock-out embryos show that loss of Lzts2 enhances cell growth. These data provide the first line of evidence demonstrating that deletion of Lzts2 increases susceptibility to spontaneous and carcinogen-induced tumor development.</pubmed_abstract><journal>The Journal of biological chemistry</journal><pubmed_title>Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development.</pubmed_title><pmcid>PMC3567628</pmcid><funding_grant_id>CA-070297</funding_grant_id><funding_grant_id>CA-151623</funding_grant_id><funding_grant_id>R01 CA070297</funding_grant_id><funding_grant_id>R01 CA151623</funding_grant_id><funding_grant_id>R29 CA070297</funding_grant_id><pubmed_authors>Luong R</pubmed_authors><pubmed_authors>Peng Y</pubmed_authors><pubmed_authors>Shaltouki A</pubmed_authors><pubmed_authors>Johnson DT</pubmed_authors><pubmed_authors>Lee JT</pubmed_authors><pubmed_authors>Lin D</pubmed_authors><pubmed_authors>Lee SH</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Sun Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development.</name><description>Using an Lzts2 knock-out mouse model, we characterized the biological role of Lzts2 in tumorigenesis. Both heterozygous and homozygous deletion of the Lzts2-targeted allele in mice shows an increased incidence in spontaneous tumor development, although Lzts2 homozygous knock-out mice show significantly higher incidences than heterozygous mice. Treatment of Lzts2-deficient mice with a carcinogen, N-butyl-N-(4-hydroxybutyl) nitrosamine, increases the susceptibility to N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder carcinoma development. Examination of human prostate cancer tissue specimens shows a reduction of LZTS2 protein expression in prostate cancer cells. Further analyses of mouse embryonic fibroblasts isolated from Lzts2 knock-out embryos show that loss of Lzts2 enhances cell growth. These data provide the first line of evidence demonstrating that deletion of Lzts2 increases susceptibility to spontaneous and carcinogen-induced tumor development.</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Feb</publication><modification>2021-02-28T08:22:03Z</modification><creation>2019-03-27T01:04:32Z</creation></dates><accession>S-EPMC3567628</accession><cross_references><pubmed>23275340</pubmed><doi>10.1074/jbc.m112.417568</doi><doi>10.1074/jbc.M112.417568</doi></cross_references></HashMap>